1. Home
  2. APLS vs USAC Comparison

APLS vs USAC Comparison

Compare APLS & USAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • USAC
  • Stock Information
  • Founded
  • APLS 2009
  • USAC 1998
  • Country
  • APLS United States
  • USAC United States
  • Employees
  • APLS N/A
  • USAC N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • USAC Natural Gas Distribution
  • Sector
  • APLS Health Care
  • USAC Utilities
  • Exchange
  • APLS Nasdaq
  • USAC Nasdaq
  • Market Cap
  • APLS 3.5B
  • USAC 2.9B
  • IPO Year
  • APLS 2017
  • USAC N/A
  • Fundamental
  • Price
  • APLS $23.80
  • USAC $23.34
  • Analyst Decision
  • APLS Buy
  • USAC Hold
  • Analyst Count
  • APLS 20
  • USAC 4
  • Target Price
  • APLS $33.47
  • USAC $25.50
  • AVG Volume (30 Days)
  • APLS 2.3M
  • USAC 307.3K
  • Earning Date
  • APLS 11-04-2025
  • USAC 11-04-2025
  • Dividend Yield
  • APLS N/A
  • USAC 9.00%
  • EPS Growth
  • APLS N/A
  • USAC 24.37
  • EPS
  • APLS N/A
  • USAC 0.66
  • Revenue
  • APLS $754,649,000.00
  • USAC $981,219,000.00
  • Revenue This Year
  • APLS $22.11
  • USAC $7.21
  • Revenue Next Year
  • APLS N/A
  • USAC $4.61
  • P/E Ratio
  • APLS N/A
  • USAC $35.15
  • Revenue Growth
  • APLS 20.02
  • USAC 8.22
  • 52 Week Low
  • APLS $16.10
  • USAC $21.24
  • 52 Week High
  • APLS $35.72
  • USAC $30.10
  • Technical
  • Relative Strength Index (RSI)
  • APLS 47.98
  • USAC 43.08
  • Support Level
  • APLS $21.07
  • USAC $23.81
  • Resistance Level
  • APLS $23.50
  • USAC $24.30
  • Average True Range (ATR)
  • APLS 0.80
  • USAC 0.53
  • MACD
  • APLS -0.03
  • USAC -0.02
  • Stochastic Oscillator
  • APLS 78.45
  • USAC 29.47

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About USAC USA Compression Partners LP Common Units Representing Limited Partner Interests

USA Compression Partners LP provides compression services in the United States in terms of total compression fleet horsepower to customers relating to infrastructure applications, including both allowing for the processing and transportation of natural gas through the domestic pipeline system and enhancing crude oil production through artificial lift processes. It engineers, designs, operates, services, and repairs its compression units and maintains related support inventory and equipment. The company provides compression services in several shale plays throughout the U.S., including the Utica, Marcellus, Permian, Denver-Julesburg, Eagle Ford, Mississippi Lime, Granite Wash, Woodford, Barnett, and Haynesville.

Share on Social Networks: